Poxel
ID: 5290871Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.
1
Funding Rounds
$20.3m
Money raised
Recent Funding Rounds
Overview
Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.
- Websites:
- Headquarters: Lyon
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Poxel has raised a total of $20.3m in funding over 1 rounds.
Key Insights:
- Poxel Series A round: $20.3m
Poxel Series A round
$20.3m
Industries
Poxel is active in the following industries: